Table 4.
Relationship between respiratory syncytial virus (RSV) and clinical data in children with RSV infection
| Characteristic | RSV viral load (copies/mL) | RSV A (n = 13) | RSV B (n = 39) |
|---|---|---|---|
| Rectal temperature | |||
| ≥38°C | (5.50 × 105) ± (2.01 × 106) | 3 (25.0) | 11 (28.2) |
| <38°C | (4.20 × 105) ± (7.89 × 105) | 10 (75.0) | 28 (71.8) |
| Severe symptoms | |||
| Tachypnoea ≥60 breaths/min | (3.53 × 105) ± (8.17 × 105) | 8 (61.5) | 22 (56.4) |
| Breath rate <60 breaths/min | (6.59 × 105) ± (2.39 × 106) | 5 (38.5) | 17 (43.6) |
| Pulse oximetry <92% | (7.06 × 105) ± (1.42 × 106) | 3 (23.1) | 9 (23.1) |
| Pulse oximetry ≥92% | (4.75 × 105) ± (1.74 × 106) | 10 (76.9) | 30 (76.9) |
| X‐ray | |||
| Evidence of pneumonia | (6.03 × 105) ± (1.79 × 106) | 6 (46.2) | 19 (48.7) |
| No evidence of pneumonia | (5.40 × 105) ± (2.10 × 106) | 7 (53.8) | 20 (51.3) |
| Drug administration | |||
| Antibiotics | (5.49 × 105) ± (3.10 × 106) | 5 (38.5) | 18 (46.2) |
| No antibiotics | (5.10 × 105) ± (1.49 × 106) | 8 (61.5) | 21 (53.8) |
| Intravenous fluids | (4.17 × 105) ± (1.76 × 106) | 6 (46.2) | 20 (51.3) |
| No intravenous fluids | (5.12 × 105) ± (1.82 × 105) | 7 (53.8) | 19 (48.7) |
| Duration of hospitalization | |||
| <4 days | (6.77 × 105) ± (2.40 × 106) | 6 (46.2) | 19 (48.7) |
| ≥4 days | (4.27 × 105) ± (9.98 × 105) | 7 (53.8) | 20 (51.3) |
| Recurrent wheezing in the following 6 months | |||
| At least one episode of wheezing | (8.27 × 105) ± (2.10 × 106)* | 8 (61.5) | 24 (61.5) |
| No wheezing | (9.88 × 102) ± (2.41 × 103) | 5 (38.5) | 15 (38.5) |
Percentages in parentheses. RSV, respiratory syncytial virus.
*p <0.05 vs. no wheezing.